There’s new hope for sufferers of the common skin disorder rosacea, with the greenlighting of a new cream that promises to offer much-needed relief.

The medication, known as Soolantra, is already showing promising results for those diagnosed with the non-contagious inflammatory skin condition.

Nathan Ponchard, 42, said he has tried all manner of treatments, from laser therapy, to pills and gel, in a bid to conquer his lifelong symptoms.

He said that after trying Soolantra, he has noticed a drastic improvement.

“I haven’t noticed not one single piece of dryness the whole time I’ve been on it, which is great, in combination with the fact that the redness isn’t as bad as it was before,” Mr Ponchard told 9NEWS.

“Mine’s not completely fixed but it’s definitely on its way to being, I dunno, normal.”

Soolantra has just been approved for use in Australia.

Dermatologist Dr John Sullivan says that unlike a lot of products marketed towards rosacea sufferers, the cream doesn’t irritate the skin and exacerbate symptoms.

A single tube of cream is expected to last patients about six weeks, and retails for between $50 to $55 dollars.

The government has no immediate plans to list Soolantra on the Pharmaceutical Benefits Scheme.

More than a million Australians are estimated to suffer from rosacea.

The condition typically sets in after adolescence, with many cases often going undiagnosed.

The original article is at: 9news.com.au